Read + Share
Amedeo Smart
Independent Medical Education
Liu Y, Yan F, Jiang VC, Li Y, et al. Pirtobrutinib and venetoclax combination overcomes resistance to targeted and CAR Tcell therapy in aggressive mantle cell lymphoma. Haematologica 2022 Dec 7. doi: 10.3324/haematol.2022.282031.PMID: 36475521
Email
LinkedIn
Facebook
Twitter
Privacy Policy